Rx (Prescription Medicine)
USD $ 35.00
Tunib 12.5mg Capsule 是一种用于治疗特定类型癌症的靶向治疗药物。其活性成分——衍生自该名称的分子——通过抑制对癌细胞生长与存活至关重要的特定蛋白质起作用。通过阻断这些通路，Tunib 能减缓或停止疾病的进展。它由肿瘤科医生为已被诊断为特定恶性肿瘤且该作用机制具有益处的患者处方使用。典型的剂量和给药方案将由主治医生根据个体的病情及对治疗的反应来确定。与任何药物一样，Tunib 可能引起副作用，副作用范围从轻微到严重不等。常见的副作用可能包括疲劳、恶心、腹泻和皮肤反应。患者应立即向医生报告任何持续或令人烦恼的副作用。Tunib 12.5mg Capsules 应储存在室温下，避免潮湿和直射阳光，并放在儿童不易触及的地方。始终严格遵循医生的用药指示。
| Molecule | |
|---|---|
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type | |
| Brand Name |
其他品牌的 Sunitinib 12.5 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
